Menu
ETF
Annual · values2025202420232022202120202019
Operating Cash Flow37.48 M USD16.13 M USD21.75 M USD-106.60 M USD-28.36 M USD-12.44 M USD1.73 M USD
Depreciation & Amortization3.85 M USD9.94 M USD11.33 M USD7.16 M USD4.49 M USD2.55 M USD1.38 M USD
Stock-Based Compensation14.82 M USD26.70 M USD22.54 M USD28.50 M USD12.42 M USD363000 USD103000 USD
Capital Expenditures303000 USD756000 USD3.83 M USD10.85 M USD11.20 M USD3.50 M USD8.77 M USD
Cash Flow from Investing-5.16 M USD-6.79 M USD-31.51 M USD-18.87 M USD-37.73 M USD-3.82 M USD-12.48 M USD
Cash Flow from Financing-174.93 M USD-158.34 M USD-37.45 M USD-205.24 M USD959.03 M USD18.27 M USD14.58 M USD
Dividends Paid
Stock Buybacks0 USD0 USD30.16 M USD160.00 M USD0 USD154000 USD0 USD
Free Cash Flow37.18 M USD15.38 M USD17.93 M USD-117.45 M USD-39.56 M USD-15.94 M USD-7.05 M USD

The Beauty Health Company designs, develops, manufactures, markets, and sells esthetic technologies and products focused on professional skin health treatments. Its flagship brand, Hydrafacial, delivers personalized facials that cleanse, extract, and hydrate the skin using proprietary serums and solutions through advanced delivery systems like Syndeo devices. Complementary offerings include SkinStylus, a microneedling and nanoneedling device for treating hypertrophic scars and acne scarring on specific skin types, and Keravive, featuring peptide solutions and take-home sprays for scalp health. The company also provides consumables such as single-use tips and boosters like Hydralock HA and HydraFillic with Pep9, enhancing treatment efficacy. Operating a skin health ecosystem, it supports providers via the MyBeautyHealth mobile app for consumer loyalty, personalized plans, and provider connections. Serving estheticians, dermatologists, and plastic surgeons across the Americas, Asia-Pacific, Europe, the Middle East, and Africa, The Beauty Health Company, founded in 1997 and headquartered in Long Beach, California, plays a key role in the professional aesthetics market by emphasizing recurring revenue from consumables and innovative, science-backed solutions.